查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930138

全球基因检测市场：市场规模、市场占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测（2026-2034）

Genetic Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 请询问到货日

价格

基因检测市场成长因子

全球基因检测市场已成为现代医学的关键支柱，这主要得益于分子生物学的快速发展、疾病盛行率的上升以及个人化医疗的日益普及。根据 Fortune Business Insights 预测，该市场规模预计将在 2025 年达到 373.2 亿美元，从 2026 年的 412.2 亿美元增长到 2034 年的 939.4 亿美元，预测期内复合年增长率 (CAGR) 为 10.85%。

北美地区凭藉其强大的医疗基础设施、技术领先优势以及对基因检测益处的高度认知，在 2025 年占市场主导地位，市场占有率为 41.67%。

市场定义与范围

基因检测透过分析DNA、染色体或蛋白质来检测可能促使或增加遗传疾病风险的基因突变或改变。这些检测广泛用于疾病诊断、风险评估、治疗方案製定和预防保健。该市场包括用于肿瘤学、产前检测、药物基因组学和心臟病等领域的各种产品（仪器和耗材）和服务。

市场驱动因素

慢性病和遗传病患病率上升

癌症、糖尿病、镰状细胞疾病、囊性纤维化和唐氏症等慢性病和遗传疾病的盛行率上升是市场成长的主要驱动因素。根据世界卫生组织估计，2000年至2021年间，镰状细胞疾病患者人数预计将显着增加，凸显了早期准确基因诊断的必要性。 此外，人口老化、久坐不动的生活方式和吸烟习惯等因素促使疾病发生率上升，从而推动了对基因检测的需求。

新产品发布激增

先进诊断测试的持续创新和频繁的新产品发布正在推动市场扩张。各公司正在肿瘤学、心臟病学和传染病领域增加高精度检测的应用。预计主要公司的策略性併购和地理扩张将在预测期内进一步增强市场成长。

市场限制因子

熟练技术人员短缺

熟练实验室技术人员短缺是主要的限制因素，尤其是在新兴经济体。先进设备的匮乏、培训不足和实验室基础设施不完善阻碍了基因检测服务的有效应用，为市场成长带来了挑战。

市场机会

数位化及与电子健康纪录 (EHR) 的整合

将基因检测数据与电子健康记录 (EHR) 整合，蕴藏着巨大的成长机会。数位化决策支援工具、人工智慧驱动的分析以及基因咨询聊天机器人正在简化工作流程，并改善临床决策。诊断公司与 EHR 供应商之间的合作，确保了检测申请和结果解读的无缝衔接，从而改善患者的治疗效果。

市场挑战

监理与伦理问题

基因检测市场面临着与资料隐私、知情同意以及潜在的基因歧视相关的复杂监管和伦理挑战。不同地区的监管框架差异显着，为製造商和服务提供者带来了合规方面的复杂性。此外，儘管检测成本正在下降，但高昂的自付费用仍然限制了成本敏感型市场的普及。

市场趋势

转向居家和直接面向消费者（DTC）的侦测

最显着的趋势之一是居家和直接面向消费者（DTC）的基因检测试剂盒日益普及。人们对预防保健意识的提高以及检测技术的进步正在推动对价格合理、便捷的检测解决方案的需求。基因数据整合到电子健康记录（EHR）系统以及个人化医疗的兴起进一步推动了这一趋势。

细分市场分析

  • 依类型划分：由于全球诊断实验室数量的增加，服务细分市场正在推动市场成长。受检测量增加和耗材频繁使用的影响，产品细分市场将在2026年占全球市场的48.81%。
  • 依技术划分：由于其高精度和对精准医疗的适用性，下一代定序（NGS）将占最大的市场占有率。 预计到 2026 年，PCR 领域将占 46.0% 的市场占有率，这主要得益于临床应用的不断增长。
  • 依应用领域划分：肿瘤领域预计将在 2026 年占市场主导地位，市场占有率达到 55.63%，这主要得益于癌症发病率的上升和对早期诊断的需求。

区域展望

  • 北美：预计到 2025 年，北美市场规模将达到 155.5 亿美元，其中美国市场预计在 2026 年将达到 156.4 亿美元。
  • 欧洲：预计欧洲市场将保持温和成长，主要得益于研发投入的增加。德国和英国将继续保持主要贡献者的地位。
  • 亚太地区：预计中国、日本和印度市场将强劲成长，这主要得益于政府精准医疗计画的推动，预计亚太地区的复合年增长率 (CAGR) 将最高。
  • 拉丁美洲、中东和非洲：预期成长温和，主要受医疗保健投资和诊断服务可近性提高的推动。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家主要疾病流行情形（2025 年）
  • 主要公司新产品发布及核准状况
  • 关键产业趋势：併购、业务合作等
  • 新冠疫情对市场的影响

第五章 全球基因检测市场分析:考察与预测(2021～2034年)

  • 市场分析、洞察与预测：依类型划分
    • 产品
      • 设备
      • 耗材
    • 服务
  • 市场分析、洞察与预测：依技术划分
    • 次世代定序 (NGS)
    • 聚合酶炼式反应 (PCR)
    • 微阵列
    • 原位杂交
    • 其他
  • 市场分析、洞察与预测：依应用划分
    • 肿瘤学
    • 产前检测
    • 药物基因组学
    • 心臟病
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美基因检测市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲基因检测市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 其他欧洲国家

第八章：亚太地区基因检测市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 印度
    • 日本
    • 韩国
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲基因检测市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章 中东与非洲基因检测市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会（GCC）国家
    • 南非
    • 其他中东和非洲国家非洲

第11章 竞争分析

  • 世界市场占有率分析(2025年)
  • 企业简介
    • Hoffmann-La Roche Ltd.
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc
    • Oxford Nanopore Technologies plc.
    • Laboratory Corporation of America Holdings
    • Agilent Technologies, Inc.
    • Myriad Genetics, Inc.
    • QIAGEN
    • Quest Diagnostics Incorporated.
    • Danaher Corporation
Product Code: FBI105590

Growth Factors of genetic testing Market

The global genetic testing market has emerged as a critical pillar of modern healthcare, driven by rapid advances in molecular biology, rising disease prevalence, and growing adoption of personalized medicine. According to Fortune Business Insights, the market was valued at USD 37.32 billion in 2025 and is projected to grow from USD 41.22 billion in 2026 to USD 93.94 billion by 2034, registering a CAGR of 10.85% during the forecast period.

In 2025, North America dominated the market with a 41.67% share, supported by strong healthcare infrastructure, technological leadership, and high awareness of genetic testing benefits.

Market Definition and Scope

Genetic testing involves the analysis of DNA, chromosomes, or proteins to detect genetic mutations or variations that may cause or increase the risk of inherited disorders. These tests are widely used for disease diagnosis, risk assessment, treatment planning, and preventive healthcare. The market comprises products (equipment and consumables) and services, catering to applications such as oncology, prenatal testing, pharmacogenomics, cardiology, and others.

Market Drivers

Rising Prevalence of Chronic and Genetic Disorders

The increasing burden of chronic and genetic diseases such as cancer, diabetes, sickle cell disease, cystic fibrosis, and Down syndrome is a major driver of market growth. According to global health estimates, the number of individuals living with sickle cell disease rose significantly between 2000 and 2021, highlighting the growing need for early and accurate genetic diagnosis. Additionally, the rising elderly population, sedentary lifestyles, and tobacco exposure are contributing to higher disease incidence, thereby boosting demand for genetic testing.

Surge in New Product Launches

Continuous innovation and frequent launches of advanced diagnostic tests are accelerating market expansion. Companies are increasingly introducing high-precision tests for oncology, cardiology, and infectious diseases. Strategic mergers, acquisitions, and geographic expansion by leading players further strengthen market growth during the forecast period.

Market Restraints

Shortage of Skilled Professionals

A key restraining factor is the shortage of skilled laboratory technologists, especially in emerging economies. Limited access to advanced equipment, insufficient training, and inadequate laboratory infrastructure restrict the effective adoption of genetic testing services, posing challenges to market growth.

Market Opportunities

Digitalization and EHR Integration

The integration of genetic testing data with Electronic Health Records (EHRs) presents a significant growth opportunity. Digital decision-support tools, AI-enabled analytics, and genetic counseling chatbots are streamlining workflows and improving clinical decision-making. Collaborations between diagnostic companies and EHR vendors enable seamless test ordering and result interpretation, enhancing patient outcomes.

Market Challenges

Regulatory and Ethical Concerns

The genetic testing market faces complex regulatory and ethical challenges related to data privacy, informed consent, and potential genetic discrimination. Regulatory frameworks vary significantly across regions, creating compliance complexities for manufacturers and service providers. Additionally, despite declining test costs, high out-of-pocket expenses continue to limit adoption in cost-sensitive markets.

Market Trends

Shift Toward At-Home and DTC Testing

One of the most prominent trends is the growing adoption of at-home and direct-to-consumer (DTC) genetic testing kits. Increased awareness of preventive healthcare and advancements in testing technologies have fueled demand for affordable, convenient testing solutions. Integration of genetic data into EHR systems and the rise of personalized medicine further support this trend.

Segmentation Analysis

  • By Type: The services segment dominated the market due to the rising number of diagnostic laboratories worldwide. The product segment, contributing 48.81% globally in 2026, benefits from increased testing volumes and frequent consumable usage.
  • By Technique: Next-Generation Sequencing (NGS) holds the largest share owing to its high accuracy and suitability for precision medicine. The PCR segment accounts for 46.0% market share in 2026, driven by widespread clinical adoption.
  • By Application: The oncology segment dominated with a 55.63% share in 2026, supported by the rising prevalence of cancer and demand for early diagnosis.

Regional Outlook

  • North America: Valued at USD 15.55 billion in 2025, with the U.S. market reaching USD 15.64 billion in 2026.
  • Europe: Moderate growth supported by R&D investments; Germany and the UK remain key contributors.
  • Asia Pacific: Expected to grow at the highest CAGR, with China, Japan, and India showing strong expansion due to government precision-medicine initiatives.
  • Latin America & Middle East & Africa: Gradual growth driven by healthcare investments and improving diagnostic access.

Competitive Landscape

The market is partially consolidated, with major players including Hoffmann-La Roche Ltd., Illumina, Inc., QIAGEN, and Quest Diagnostics Incorporated. These companies focus on innovation, strategic collaborations, and portfolio expansion to maintain competitive advantage.

Conclusion

In conclusion, the global genetic testing market is set for robust growth from USD 37.32 billion in 2025 to USD 93.94 billion by 2034, driven by technological advancements, rising disease prevalence, and increasing adoption of personalized medicine. While regulatory complexities and workforce shortages pose challenges, ongoing innovation, digital integration, and expanding healthcare access are expected to sustain long-term market expansion and transform the future of precision diagnostics.

Segmentation By Type

  • Products
    • Equipment
    • Consumables
  • Services

By Technique

  • Next-generation Sequencing (NGS)
  • Polymerase Chain Reaction
  • Microarrays
  • In-situ Hybridization
  • Others

By Application

  • Oncology
  • Prenatal Testing
  • Pharmacogenomics
  • Cardiology
  • Others

By Region

  • North America (By Type, Technique, Application, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Technique, Application, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Technique, Application, and Country/Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Technique, Application, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Technique, Application, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, By Key Countries, 2025
  • 4.2. New Product Launches/ Approvals, By Key Players
  • 4.3. Key Industry Developments- Mergers, Partnerships, Acquisitions, etc.
  • 4.4. Impact of COVID-19 on the Market

5. Global Genetic Testing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Products
      • 5.1.1.1. Equipment
      • 5.1.1.2. Consumables
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Technique
    • 5.2.1. Next-generation Sequencing (NGS)
    • 5.2.2. Polymerase Chain Reaction
    • 5.2.3. Microarrays
    • 5.2.4. In-situ Hybridization
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Oncology
    • 5.3.2. Prenatal Testing
    • 5.3.3. Pharmacogenomics
    • 5.3.4. Cardiology
    • 5.3.5. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Genetic Testing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Products
      • 6.1.1.1. Equipment
      • 6.1.1.2. Consumables
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Technique
    • 6.2.1. Next-generation Sequencing (NGS)
    • 6.2.2. Polymerase Chain Reaction
    • 6.2.3. Microarrays
    • 6.2.4. In-situ Hybridization
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Oncology
    • 6.3.2. Prenatal Testing
    • 6.3.3. Pharmacogenomics
    • 6.3.4. Cardiology
    • 6.3.5. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Genetic Testing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Products
      • 7.1.1.1. Equipment
      • 7.1.1.2. Consumables
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Technique
    • 7.2.1. Next-generation Sequencing (NGS)
    • 7.2.2. Polymerase Chain Reaction
    • 7.2.3. Microarrays
    • 7.2.4. In-situ Hybridization
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Oncology
    • 7.3.2. Prenatal Testing
    • 7.3.3. Pharmacogenomics
    • 7.3.4. Cardiology
    • 7.3.5. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Scandianvia
    • 7.4.7. Rest of Europe

8. Asia Pacific Genetic Testing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Products
      • 8.1.1.1. Equipment
      • 8.1.1.2. Consumables
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Technique
    • 8.2.1. Next-generation Sequencing (NGS)
    • 8.2.2. Polymerase Chain Reaction
    • 8.2.3. Microarrays
    • 8.2.4. In-situ Hybridization
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Oncology
    • 8.3.2. Prenatal Testing
    • 8.3.3. Pharmacogenomics
    • 8.3.4. Cardiology
    • 8.3.5. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. China
    • 8.4.2. India
    • 8.4.3. Japan
    • 8.4.4. South Korea
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Genetic Testing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Products
      • 9.1.1.1. Equipment
      • 9.1.1.2. Consumables
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Technique
    • 9.2.1. Next-generation Sequencing (NGS)
    • 9.2.2. Polymerase Chain Reaction
    • 9.2.3. Microarrays
    • 9.2.4. In-situ Hybridization
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Oncology
    • 9.3.2. Prenatal Testing
    • 9.3.3. Pharmacogenomics
    • 9.3.4. Cardiology
    • 9.3.5. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Genetic Testing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Products
      • 10.1.1.1. Equipment
      • 10.1.1.2. Consumables
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Technique
    • 10.2.1. Next-generation Sequencing (NGS)
    • 10.2.2. Polymerase Chain Reaction
    • 10.2.3. Microarrays
    • 10.2.4. In-situ Hybridization
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Oncology
    • 10.3.2. Prenatal Testing
    • 10.3.3. Pharmacogenomics
    • 10.3.4. Cardiology
    • 10.3.5. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Hoffmann-La Roche Ltd.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Illumina, Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Thermo Fisher Scientific Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Bio-Rad Laboratories, Inc
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Oxford Nanopore Technologies plc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Laboratory Corporation of America Holdings
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Agilent Technologies, Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Myriad Genetics, Inc.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. QIAGEN
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Quest Diagnostics Incorporated.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. Danaher Corporation
      • 11.2.11.1. Overview
      • 11.2.11.2. Products & services
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 3: Global Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 4: Global Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Genetic Testing Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 7: North America Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 8: North America Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 9: North America Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 10: North America Genetic Testing Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 12: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 13: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 14: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 17: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 18: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 19: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 20: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 22: Latin America Genetic Testing Market Revenue (USD billion) Forecast, by Products 2021-2034
  • Table 23: Latin America Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 24: Latin America Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 25: Latin America Genetic Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 27: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 28: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 29: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 30: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Genetic Testing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Genetic Testing Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Genetic Testing Market Value Share (%), by Technique, 2025 & 2034
  • Figure 4: Global Genetic Testing Market Value Share (%), by Application, 2025 & 2034
  • Figure 5: Global Genetic Testing Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 7: North America Genetic Testing Market Value Share (%), by Type, 2025
  • Figure 8: North America Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 9: North America Genetic Testing Market Value Share (%), by Technique, 2025
  • Figure 10: North America Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 11: North America Genetic Testing Market Value Share (%), by Application, 2025
  • Figure 12: North America Genetic Testing Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Genetic Testing Market Value Share (%), By Country, 2025
  • Figure 14: Europe Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Genetic Testing Market Value Share (%), by Type, 2025
  • Figure 16: Europe Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 17: Europe Genetic Testing Market Value Share (%), by Technique, 2025
  • Figure 18: Europe Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 19: Europe Genetic Testing Market Value Share (%), by Application, 2025
  • Figure 20: Europe Genetic Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Genetic Testing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Genetic Testing Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 25: Asia Pacific Genetic Testing Market Value Share (%), by Technique, 2025
  • Figure 26: Asia Pacific Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 27: Asia Pacific Genetic Testing Market Value Share (%), by Application, 2025
  • Figure 28: Asia Pacific Genetic Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Genetic Testing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Latin America Genetic Testing Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 33: Latin America Genetic Testing Market Value Share (%), by Technique, 2025
  • Figure 34: Latin America Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 35: Latin America Genetic Testing Market Value Share (%), by Application, 2025
  • Figure 36: Latin America Genetic Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Genetic Testing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Genetic Testing Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 41: Middle East & Africa Genetic Testing Market Value Share (%), by Technique, 2025
  • Figure 42: Middle East & Africa Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 43: Middle East & Africa Genetic Testing Market Value Share (%), by Application, 2025
  • Figure 44: Middle East & Africa Genetic Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Genetic Testing Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Genetic Testing Market Share (%), By Company, 2025